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Abstract A first episode of depression after 65 years of
age has long been associated with both severe macrovas-
cular and small microvascular pathology. Among the three
more frequent forms of depression in old age, post-stroke
depression has been associated with an abrupt damage of
cortical circuits involved in monoamine production and
mood regulation. Late-onset depression (LOD) in the
absence of stroke has been related to lacunes and white
matter lesions that invade both the neocortex and subcor-
tical nuclei. Recurrent late-life depression is thought to
induce neuronal loss in the hippocampal formation and
white matter lesions that affect limbic pathways. Despite
an impressive number of magnetic resonance imaging
(MRI) studies in this field, the presence of a causal rela-
tionship between structural changes in the human brain and
LOD is still controversial. The present article provides a
critical overview of the contribution of neuropathology in
post-stroke, late-onset, and late-life recurrent depression.
Recent autopsy findings challenge the role of stroke loca-
tion in the occurrence of post-stroke depression by pointing
to the deleterious effect of subcortical lacunes. Despite the
lines of evidences supporting the association between MRI-
assessed white matter changes and mood dysregulation,
lacunes, periventricular and deep white matter demyelina-
tion are all unrelated to the occurrence of LOD. In the same
line, neuropathological data show that early-onset depres-
sion is not associated with an acceleration of aging-related
neurodegenerative changes in the human brain. However,
they also provide data in favor of the neurotoxic theory of
depression by showing that neuronal loss occurs in the
hippocampus of chronically depressed patients. These three
paradigms are discussed in the light of the complex rela-
tionships between psychosocial determinants and biological
vulnerability in affective disorders.
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Introduction
Mood disorders in late life are seen as the final byproduct
of complex interactions between genetic predispositions,
environmental influences, and neurobiological abnormali-
ties [7, 14, 16, 88, 97]. Depressive illness is projected to be
the second leading cause of disease burden after ischemic
heart disease by year 2020 [145]. With the demographic
transition observed in most Western countries, this burden
is progressively shifting towards the older age groups.
Clinically significant depressive syndromes can be found in
8–16 % of community-dwelling, about 25 % of primary
care, and 23 % of hospitalized older adults (i.e., adults
aged 60 years or older) [18, 112], and are associated with
disability, decline in overall health, increased use of
medical services and increased mortality rates through sui-
cide and complications of comorbid diseases [6, 15, 67, 71].
A large number of older adults develop depression for the
first time in their lives after age of 60, often in the presence
of multiple health problems [85, 86]. Introducing the
concept of ‘‘arteriosclerotic depressive disease’’ in his 1905
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treatise, Gaupp [51] was the first to consider the impact of
cerebrovascular pathology on mood regulation. The rela-
tionship between the accumulation of vascular lesions in
the human brain and affective disorders remained, how-
ever, controversial before the experimental work of
Robinson and collaborators [102] who demonstrated the
role of middle cerebral artery lesions in the development of
behavioral and cellular changes compatible with depres-
sion. Progressively, three apparently distinct theoretical
models have been developed to describe the complex
interactions between vascular burden and emotional dis-
turbances in late life. The first one referred to the traumatic
consequences of acute vascular pathology and was initially
based on the higher incidence of depression in elderly
patients during the 2-year period following stroke as
compared to those having a comparable degree of disability
caused by other medical conditions [47]. According to the
first description of this model, stroke induces an abrupt
biological stress not only by affecting cortical circuits
involved in the emotional regulation and cognitive
appraisal but also by interrupting the projections ascending
from midbrain and brainstem, leading to a decreased bio-
availability of the biogenic amines. This traumatic status of
the human brain may increase the psychological reactions
that are usually present in chronic medical conditions
characterized by increased functional disabilities (for
review see [1, 69, 83]). In contrast to this conceptualization
that points to the catastrophic impact of acute brain damage
on mood, the second model focused on the progressive
accumulation of small macrovascular and microvascular
lesions in old age and its possible neurocognitive and
affective repercussions. It highlighted the impact of an
existing burden of vascular pathology on the development
of first episodes of depression in late life. The terms of
vascular depression and depression-executive dysfunction
syndrome attempted to define the morphological substrates
of the atypical clinical expression of depressive illness in
the elderly, regrouping psychiatric, neuropsychological
and, in certain cases, pure neurological symptoms [12, 121,
122, 128]. Besides the possible causal link between vas-
cular burden and first episode of depression after 65 years
of age, the neurotoxic hypothesis of depression provided an
attractive theoretical framework to explain the concomitant
presence of mood dysregulation and cognitive deficits in
elderly patients with long-lasting depression. Unlike the
two previous models that mainly concern the first episodes
of depression in late life, no distinctive histopathology was
incriminated here, the persistence of clinical symptoms
over time thought to be the indirect consequence of neu-
ronal and synaptic loss caused by neuroendocrine
abnormalities [54, 66, 100, 101, 108, 116]. To examine the
pertinence of these models, we provide here a compre-
hensive review of the morphological correlates of
depression in late life combining structural neuroimaging
contributions and neuropathological validation studies. To
facilitate reading and despite the unavoidable overlap of
the neurobiological mechanisms surrounding post-stroke,
late-onset and recurrent late-life depression, we opted to
describe each model separately before commenting on their
pertinence.
Post-stroke depression: the traumatic model of late-life
mood disorders
Post-stroke depression affects one-third of stroke survivors
[57] and is associated with poor functional recovery,
decreased quality of life, and increased mortality [109].
Besides the core signs of depression, the main clinical
symptoms include catastrophic reactions, hyperemotional-
ity, and diurnal mood changes [50]. Early-onset forms
(\6 months post-stroke) are characterized by frequent
anxiety, loss of libido, and feelings of guilt, whereas late-
onset cases display social isolation and diurnal mood
changes [98]. However, these descriptions are by far not
widely accepted. A recent study from Cumming et al. [38]
explored further the claims for a phenomenologic distinc-
tion between post-stroke depression (PSD) and depression
without brain injury and reported a broadly similar symp-
tomatic profile with the exception of ‘‘inability to feel’’ and
‘‘disturbed sleep’’ levels that were significantly higher in
non-PSD depressed patients.
The relevance of stroke location in PSD: MRI findings
Stroke location has been long considered as the main
determinant of PSD. The initial concept was that abrupt
ischemia interrupts the projections ascending from mid-
brain and brainstem, leading to a decreased bioavailability
of the biogenic amines—serotonin (5HT), dopamine (DA)
and norepinephrine (NE) and possibly acetylcholine (for
review see [83]). Subsequently, cases with a massive
damage of frontal lobe association and limbic areas may be
more prone to mood disorders compared to those with
posterior parietal or occipital lobe macroinfarcts. To
explore the validity of this hypothesis, several magnetic
resonance imaging (MRI) studies were conducted in
patients with PSD by the end of 1990s. Robinson et al.
[104] reported first a 2-year longitudinal study and found
that patients with left-sided frontal cerebral lesions were
more at risk to develop PSD when compared to patients
with right hemisphere or left hemisphere posterior lesions.
This pioneer work was followed by more than 50 MRI
studies in hospital dwelling samples that led to conflicting
data. In their extensive review, Vataja et al. [141] sup-
ported the positive association between PSD and left
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prefrontal-subcortical location and volume size. However,
two systematic reviews challenged this viewpoint and
pointed to the main methodological problems of previous
studies including PSD definition, small sample sizes, and
lesion characterization [17, 30]. In a timely review based
on the analysis of 38 neuroimaging studies, Bhogal et al.
reported that the source of sampling could be a major
determinant of the relationship between stroke location and
occurrence of depression. In this work, left hemisphere
lesion location was significantly associated with PSD in
hospital-based population studies, whereas the inverse was
true in community-based studies. Carson et al. [30] found
no association between PSD and lesion location in a pooled
analysis of 34 primary studies. A cortico-subcortical
involvement of the temporal lobe and internal capsule,
increased numbers of cerebral microbleeds and deep white
matter hyperintensities were all associated with the
occurrence and severity of PSD [125, 126, 149, 150].
Microvascular lesions predict PSD: post-mortem
observations
Neuropathological explorations that may shed some light
on the anatomic substrates of PSD remain scarce. In a first
study assessing the relationship between the presence of
diffuse or focal macrovascular pathology and the occur-
rence of depressive symptoms in the first 2 years following
stroke, we did not find a significant impact of these lesions
in the development of clinically overt depression [20].
Later on, Brodaty and collaborators [24] postulated that
more than stroke location, the progressive accumulation of
small macrovascular and microvascular lesions may
determine the occurrence of PSD. To address this issue, we
assessed lacunes and microvascular lesions in 41 post-
mortem brains of stroke patients, 20 having developed PSD
and 21 without depression. The presence of lacunes in
subcortical regions, namely in the thalamus, basal ganglia,
and deep white matter was strongly related to the devel-
opment of PSD explaining 25 % of the variability of this
occurrence (Fig. 1) [106]. In conjunction with our previous
work in cognitively impaired elders, this finding suggests
that the development of subcortical lacunes may constitute
a common denominator of cognitive and mood disorders in
late life [53].
Future perspectives: combining biological
and psychological determinants of PSD
The interaction between biological determinism and psy-
chosocial mechanisms in the etiology of PSD remains,
however, a highly controversial issue [1, 45, 58, 70, 89,
103, 108]. The relationship between PSD and physical
disability is complex and certainly goes beyond the
commonly held notion that depression after stroke is a
typical consequence of physical impairment [139]. In fact,
psychological reactions to loss during stressful life periods
are at least partly biologically determined. In the same line,
even in the case of the absence of social contacts, shown to
be a main psychosocial determinant of PSD [11], the
direction of the relationship remains ambiguous as they
may be both a cause and a consequence of PSD. In a recent
attempt to conciliate the biological and psychosocial
dimensions of PSD, Hama et al. [60] proposed a distinction
between an affective PSD form with predominant depres-
sed mood and an apathetic form characterized by loss of
interest. Using specific symptom scales for each PSD
subtype, these authors aimed to correlate these symptoms
to lesion location in two sets of 243 and 101 stroke
patients, respectively. In both samples, they found that
affective PSD was associated with left frontal lobe damage
while apathetic depression was more frequent in patients
presenting with basal ganglia damage [59]. Apathy has also
Fig. 1 Representative example of a patient sufferring from late-onset
major depressive disorder. Macroscopic (a) and histological views
(low magnification in b, higher magnification in c) of multiple
lacunes in basal ganglia. b, c hematoxylin–eosin staining. Scale bar
b 6.5 mm; c 1.2 mm
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been associated with subcortical lesions by other authors
[120]. A recent SPECT study by Onoda et al. [96] found
that the lesions of left basal ganglia were associated with
hypoperfusion of bilateral basal ganglia in an apathetic
group of 37 patients when compared to 65 non-apathetic
patients with major depression. In line to conciliate the
biological and the psychological etiologic perspectives on
PSD, a recent study reported no relationship between
hemispheric location, level of social support, age, gender,
or compliance to antidepressive treatment and the devel-
opment of PSD, but a strong association between a good
response to psychosocial treatments and serotonin trans-
porter polymorphisms [73].
Neurocognitive changes and vascular burden
in late-life depression
Neuroimaging data
Several studies supported the idea that depression in older
people might have a different etiology from depression in
younger adults. For instance, individuals with early-onset
major depression are likely to have a positive family his-
tory for this disorder, whereas later age at onset of
depression has been associated with subcortical vascular
pathology [3, 23, 26, 72].
In the last decades, two main sets of experimental data
supported the presence of significant vascular pathology in
the brain of elderly individuals with depressive illness. The
first concerns diffusion tensor imaging (DTI)-based
investigation of white matter tracts that documented a great
variety of deficits affecting both neocortical association
areas and subcortical nuclei. The second refers to the fre-
quent coexistence of cognitive deficits primarily affecting
executive functions, white matter hyperintensities and late-
life depression [76, 127].
DTI is an MRI technique based on the analysis of the
diffusion of water in tissues that provides indirect evidence
about the microstructure of white matter. Fractional
anisotropy (FA) and mean diffusivity (MD) are the most
commonly assessed parameters thought to reflect white
matter integrity [148]. Several teams used DTI to investi-
gate the presence of subtle changes in white matter tracts
occurring in late-life depression [34, 39, 115, 123]. Colloby
[34] recently used the tract-based spatial statistics (TBSS)
analysis, an automated whole brain analysis method (for its
description see [142]), to detect white matter brain abnor-
malities in an elderly population of 30 controls and 38
subjects with late-onset depression (LOD). They found a
lower FA in these regions, suggesting white matter fiber
lesions of numerous tracts, such as the corpus callosum, the
uncinate fasciculus, the inferior fronto-occipital fasciculus,
the inferior longitudinal fasciculus, and the corticospinal
and corticopontine tracts. Further research in the field
attempts to identify connectivity deficits in late-life
depression. Dalby et al. [39] showed a positive correlation
between the severity of depression and loss of integrity of
white matter fiber tracts (including the left superior longi-
tudinal fasciculus and the right uncinate fasciculus) in LOD.
A study using DTI excluding white matter hyperintensities
from the analysis of an elderly depressed population, found
an increased MD in the prefrontal regions in the depressed
compared to healthy controls [115]. A new interesting
approach is the combination of structural and functional
markers to elucidate possible underlying connectivity def-
icits. Steffens et al. used DTI and the resting-state BOLD to
test whether impaired structural integrity of the uncinate
fasciculus is coupled with decreased activation of target
regions. They found positive correlations between left
uncinate fasciculus FA values and resting state functional
connectivity in left ventrolateral prefrontal cortex and
amygdala, as well as left ventrolateral prefrontal cortex and
hippocampus [123]. DTI has been lately combined with
neuropsychological assessment to identify MRI correlates
of neuropsychological impairment in elderly depressed
patients. Sexton et al. [113] found a positive correlation
between reduced FA of anterior thalamic radiation, the
corpus callosum, the uncinate fasciculus and impaired
executive function and episodic memory.
Overall, it remains quite hard to draw definite conclu-
sions from voxel-based morphometry (VBM) and DTI
findings, in spite of a large number of studies. Even though
several groups have replicated some MRI patterns, others
reported negative data. Methodological differences related
to small sample sizes, as well as the chronicity of depressive
episodes and effects of treatment, not always taken into
account in the analysis and interpretation of results, may
partly explain discrepancies. Moreover, the existence of
some of these deficits in younger depressed patients chal-
lenged their real relevance in the context of late-life
depression [37, 65, 80].
The strongest argument in favor of the neurocognitive
origin of late-life depression comes, however, from the
study of white matter hyperintensities coupled with exec-
utive deficits in old depressed patients within the
theoretical framework of the ‘‘vascular depression’’
hypothesis [124]. Executive dysfunction and episodic
memory impairment constitute the most prominent symp-
toms in patients with LOD after remission [93], and
patients with LOD present with a more frequent and rapid
cognitive decline compared to early-onset depression
(EOD) cases and controls in neuropsychological studies
[63, 74]. The first neuroimaging studies in this field pointed
to the role of white matter hyperintensities as a possible
trigger or at least correlate of LOD. According to the
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‘‘vascular depression hypothesis’’ [5], the presence of
increased white matter hyperintensities in some elders
reflects a predisposition for the development of depression,
through the fiber tract disruption of frontostriatal circuits.
In their systematic review, Herrmann et al. [64] found a
fourfold higher prevalence of deep and periventricular
WMH in LOD when compared to EOD. Similar conclu-
sions were reached by Tham [130] and colleagues in their
recent review on late-life depression. The European multi-
centre study (LADIS) investigated the relationship between
WMH, cognitive impairment and depression. After con-
trolling for cognitive impairment, these data indicate a
stronger association between deep white matter lesions and
depressive symptoms compared to periventricular ones
[76]. Recent functional MRI studies added credit to the
vascular depression concept. For instance, there was a
positive correlation between WMH burden and BOLD
fMRI activity in subgenual cingulate cortex during a facial
expression affective reactivity task supporting the idea that
high WMH burden in late-life depression disrupts the brain
mechanisms of affective regulation leading to hyperacti-
vation of limbic areas involved in mood regulation such as
hippocampus and cingulate cortex [2]. In the same line,
increased activation of the dorsomedial prefrontal cortex
during the performance of a low cognitive load event-
related task that correlated with WMH burden was recently
reported in late-life depression [147].
In our recent cross-sectional and longitudinal studies,
Delaloye et al. [41, 144] confirmed these observations in a
prospective analysis of euthymic, EOD and LOD patients
and control subjects combining MRI investigation and
neuropsychological assessment. They found a higher degree
of white matter hyperintensities in LOD patients, as well as
decreased performances in episodic memory tasks, while
euthymic EOD patients manifested a preserved episodic
memory capacity, replicating previous findings in younger
age groups [22, 74]. In the same line, a longitudinal study of
a large sample size showed that the severity of white matter
changes predicts the development of depressive symptoms
at 1 year from the baseline [129]. Together with the clinical
criteria of a more frequent presence of cardiovascular risk
factors such as hypertension, dyslipidemia and a history of
cerebrovascular disease, a higher burden of WMH was
proposed to be a diagnostic criterion for vascular depression
[5]. The same authors also introduced the concepts of
‘‘depression-executive dysfunction syndrome of late life’’
[4] and ‘‘subcortical ischemic depression’’ [75] and pro-
posed that the disruption of frontostriatal circuits by
vascular lesions constituted the main pathophysiological
mechanism underlying depressive symptoms in old age.
Despite a decade’s worth extensive literature on the
association between LOD and cardiovascular risk factors,
the underpinnings of the ‘‘vascular depression’’ construct
are still difficult to disentangle (for review see [27, 133, 137]),
and datasets from different fields seem to ascribe it dis-
similar significance. One of the points that remain
controversial is the etiologic role of WMH in late-life
depression, given their frequent association with cardio-
vascular risk factors as well as with advanced age [39, 99,
142]. Moreover, results on the validity of the symptom
profile attributed to ‘‘vascular depression’’ phenotype are
conflicting. Together with the Longitudinal Aging Study
Amsterdam (LASA) community-based results from Naard-
ing et al. [92], McDougall’s [90] recent systematic review of
the literature failed to support a clinically recognized subtype
of vascular depression [119, 137].
Besides sampling differences, several methodological
reasons may explain the observed discrepancies in neuro-
imaging studies including the pathological heterogeneity of
WMH, the frequent failure to take into account site and
lateralisation of lesions and inter-rater variability in respect
to the radiological criteria for white matter lesions (WML)
[64]. In a recent review based on neuroimaging and
neuropathological data, Casanova et al. [31] did not iden-
tify a reliable association between WMHs and depression
in different types of dementia. WML heterogeneity and its
correlation with age was also recently reviewed by Schmidt
et al. According to authors periventricular WMH seem to
have a non-vascular origin, whereas the majority of deep,
subcortical WMH correspond to incomplete ischemic
destruction [111]. Most neuroimaging–histopathological
correlations have established that WMH can correspond to
a wide variety of histologic processes such as arterioscle-
rosis, perivascular demyelination, dilated perivascular
spaces, vascular ectasia, ischemia, incomplete infarction,
partial loss of myelin and axons, gliosis, infarction with
necrosis, and congenital diverticula [21, 33, 46, 135].
The contribution of neuropathology
Post-mortem studies including rigorous neuropathological
investigation in clinically well-documented autopsy cases,
although difficult to perform, are crucial to elucidate the
role of cerebrovascular lesions in late-life affective disor-
ders [118]. Thomas and colleagues have performed pioneer
work in the neuropathological exploration of ‘‘vascular
depression hypothesis’’ with conflicting results. Although
deep white matter hyperintensities (DWMH) were more
frequently associated with ischemia in depressed patients,
mainly when located in the dorsolateral prefrontal cortex
[134, 136] and patients with depression presented an
increased frequency of cerebrovascular atheromatous
lesions, depression was not associated with small vascular
or with microvascular disease (Figs. 1, 2) [132, 134]. To
investigate this question further, we have performed a
clinico-neuropathological exploration in the post-mortem
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brains of 38 patients with LOD and 29 control subjects
[107]. Our results complemented those obtained by Thomas
et al. [131] by confirming, in a more extensive analysis that
included both more cortical regions and a separate analysis
of each type of small microvascular and microvascular
lesions, the same absence of association between cerebro-
vascular pathology and LOD, even in the subgroup of
patients fulfilling the criteria for vascular depression.
Moreover, in this same study, neither deep white matter nor
periventricular demyelination were associated with LOD.
These results seem to contradict the vascular depression
hypothesis by indicating that the chronic burden of small
vascular and microvascular lesions is not a major determi-
nant of LOD. A few months ago, Tsopelas and collaborators
reported the largest autopsy series of elderly individuals
with late-life depression from the Medical Research
Council Cognitive Function and Ageing Study [140]. A
total of 153 community-based participants (36 with late-life
depression) were autopsied. Here also, no relationship was
found between cerebrovascular pathology such as hemor-
rhages, infarcts larger than 10 mm, lacunes and small vessel
disease, and depression [108]. A possible interpretation for
this discrepancy is that the burden of subcortical lacunes
may constitute a neuroanatomical substrate for both cog-
nitive decline and affective dysregulation in old age but that
their contribution to the development of depression may be
relevant solely in the presence of a ‘‘second hit’’ such as an
episode of acute brain compromise (as in PSD) or the
accumulation of age-related neurodegenerative changes (as
in mixed cases). Alternatively, the absence of a clear
structural marker for LOD may reflect the predominant role
of psychosocial determinants. In fact, several recent studies
have highlighted the role of clinical and psychological
determinants of LOD, namely the impact of the burden of
medical comorbidities [35, 36, 86, 105], the presence and
type of treatment for depression [19], the degree of social
support [61, 84, 117, 138], the existence of functional dis-
ability [48, 81], and the psychological profile and
psychiatric status of the patient [9, 29, 35, 84]. Interestingly,
a recent review by Weber et al. [143] concludes that while
more biologically determined risk factors for depression,
such as gender or family history, seem to predict mainly
Fig. 2 Representative examples of microvascular lesions in brain
aging. Slightly asymmetric deep white matter demyelination
(a arrows), multiple cortical microinfacts (b), focal cortical gliosis
(c) and subcortical gliosis (d). a Luxol-van Gieson staining;
b–d Globus silver-impregnation. Scale bar b 800 mm, c 200 mm,
d 400 mm
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short-term changes in mood regulation, personality char-
acteristics are more closely related to the long-term
evolution and treatment of depressive episodes.
The neurotoxic hypothesis of late-life depression
Structural neuroimaging
The main piece of evidence supporting this scenario is
related to the volumetric loss in hippocampus observed in
late-life depression. Whether or not, this finding is related
to the recurrence of early-onset depressive illness or the
development of LOD remains, however, highly contro-
versial. In fact, a loss of hippocampal volume bilaterally
has been reported in VBM analyses of LOD cases unlike
EOD and healthy elderly controls [68, 82]. This was further
confirmed by another study that found greater hippocampal
volume reductions in the subiculum and the lateral-pos-
terior aspects of the CA1 in LOD compared to controls and
EOD [13]. The origin of this finding is unclear. Does small
hippocampal size render a person more vulnerable to
develop depression or is it a result of the disease? The
duration of illness [32, 91] as well as poor treatment out-
come and increased risk of relapse [49, 87] are all
associated with hippocampal volume reductions and may
thus partly explain the association between this MRI var-
iable and late-life depression. However, a recently
published 10-year prospective study of an elderly popula-
tion failed to establish the relationship between smaller
hippocampal size at baseline and subsequent development
of LOD [42]. Other VBM analyses of elderly patients with
depression revealed volume reductions in the right frontal,
orbitofrontal and anterior cingulate cortices left temporal
lobe and caudate nucleus compared to both control subjects
and EOD patients [8, 10, 25, 43, 44, 55].
Early MRI contributions have also reported decreased
hippocampal volumes in middle-aged and elderly patients
suffering from EOD [114]. Reduced hippocampal volume,
mainly in the left side, was also reported later on in
unmedicated remitted patients with major depression [94],
drug-naı¨ve depressed outpatients [110], young patients
who relapse in a 2-year follow-up [77], as well as in male
patients with a first episode of major depression [78].
Despite the impressive variability of the experimental data,
a recent meta-analysis of 32 MRI studies concluded that
hippocampal volume loss is mainly present in patients with
a duration of illness longer than 2 years and more than one
disease episode [91]. Previous comparisons between early-
onset and late-onset elderly cases led to discrepant data.
Unlike the data reported by Janssen and collaborators [68],
we found no evidence supporting hippocampal volume loss
in early-onset cases In a recent region of interest and VBM
longitudinal study [41, 144]. In the community based
SMART Medea study, early-onset was associated with
smaller hippocampal volume, whereas late-onset cases had
small entorhinal cortex volume [52].
Taking into account both the molecular and cellular
effects of chronic stress and the possible neuroprotective
impact of antidepressant treatment on hippocampus, a
recent review postulates that chronic depression may crit-
ically affect hippocampus and even be a risk factor for
Alzheimer disease [87]. Similarly, de Leeuw and collabo-
rators [40] have reported an association between increased
subcortical WMLs shown to be increased in patients with
EOD as compared to control subjects [56, 64, 79] and
decreased hippocampal volume in patients with probable
Alzheimer’s disease. The authors hypothesized that WMLs
affecting cortico-subcortical tracts linking prefrontal and
limbic areas might disrupt hippocampal function and
structure and may be associated with depressive symptoms.
Interestingly, the results of a recent correlation of MRI-
assessed hippocampal volume and cognitive performance
in a large series of patients with CADASIL (a hereditary
disorder that models pure small vessel disease [95]), con-
firmed the links between vascular burden, hippocampal
atrophy and cognitive impairment in the absence of neu-
rodegenerative process.
Lessons from neuropathology
Only rare studies attempted to explore the association
between Alzheimer’s disease pathology as well as hippo-
campal neuronal loss and late-life depression. It seems to
be a general consensus against an association between
previously ascertained depression and Alzheimer’s disease
pathology in old age. For instance, in a sample of 139
priests and nuns followed up to 4 years, depressive
symptoms were not associated with plaque and tangle
burden [146]. Similar observations were made by Hend-
ricksen and coworkers [62] and Thomas and coworkers
[131]. These observations were recently confirmed by
Tsopelas et al. [140] in the largest autopsy series of non-
demented elders with long-lasting depression. However,
these authors still found neuronal loss in hippocampus
supporting the idea of a direct effect of depression on
hippocampal volumes. Surprisingly, they also reported an
association between Lewy body densities in the brainstem
nuclei and late-life depression in some rare cases with
probable raphe pathology.
Conclusion and future perspectives
Starting from the viewpoint of three conceptually distinct
models of depressive illness in the elderly, this review
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reveals the marked difficulty to analyze the interaction
between psychosocial determinants and biological vulner-
ability over time. Although still too rare, the autopsy studies
in this complex field sometimes confirm and in other
challenge the relevance of MRI findings. In respect to post-
stroke depression, the classical paradigm of acute mood
disorder consecutive to well identified brain damage, both
MRI and autopsy studies do not support the idea of a simple
association between stroke location and mood disorder.
Going beyond structural imaging, the neuropathological
analysis in PSD cases stresses, however, the deleterious
impact of small macrovascular burden on affective regula-
tion. From this point of view, a purely traumatic model
based on the abrupt change of brain status in PSD is not
pertinent and should be revised. In contrast to PSD, LOD
was not a priori defined as the consequence of a biological
event. Attempting to establish a neurobiological origin, the
introduction of the clinico-radiological concept of vascular
depression was based on the frequently repeated, but not yet
demonstrated assumption that the disruption of subcortico-
frontal circuits is a key etiologic factor for the development
of late-life mood disorders. However, neuropathological
data challenged first the relationship between cerebrovas-
cular pathology and LOD. These observations parallel the
claims of some groups that questioned the clinical validity
of the vascular depression hypothesis by highlighting the
important role of psychosocial and personality factors in
this type of depression. For example, a recent study by
Canuto et al. [28] pointed to the role of neurocognitive and
personality dimensions in euthymic patients with mood
disorders in late life. Last but not least, despite the MRI
evidence in favor of a possibly causal link between recur-
rent depression and neurodegeneration in old age, recent
neuropathological data show that EOD is not a risk factor
for AD pathology. However, they also provide experimental
evidence in favor of the neurotoxic theory of depression by
showing that AD pathology-unrelated neuronal loss occurs
in the hippocampus of chronically depressed patients. These
three paradigms illustrate the complementarity of neurora-
diological and neuropathological observations in this field.
Although useful to structure the exploration of such
complex field, theoretical models are necessarily simplistic.
When interpreting these data, one should keep in mind that
the mechanisms underlying depression after stroke are by
far more complex than the dichotomy between biological
vulnerability and psychosocial factors. In fact, genomic
signatures, neurotransmitter and neurotrophin signaling,
hippocampal neurogenesis, cellular plasticity in the ische-
mic lesion, secondary degenerative changes, activation of
the hypothalamo–pituitary–adrenal (HPA) axis and neuro-
inflammation are all involved in the pathogenetic cascade
that precede the occurrence of depressive symptoms in this
context. Future studies assessing the role of these additional
players are clearly warranted to assess the relative weight of
biological determinants of late-life depression.
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